PuSH - Publikationsserver des Helmholtz Zentrums München

Willner, E.M.* ; Kolbe, F. ; Momburg, F.* ; Protzer, U. ; Dietz, H.*

Hepatitis B virus neutralization with DNA origami nanoshells.

ACS Appl. Mater. Interfaces 16, 25836-25842 (2024)
Verlagsversion DOI PMC
Open Access Hybrid
Creative Commons Lizenzvertrag
We demonstrate the use of DNA origami to create virus-trapping nanoshells that efficiently neutralize hepatitis B virus (HBV) in cell culture. By modification of the shells with a synthetic monoclonal antibody that binds to the HBV envelope, the effective neutralization potency per antibody is increased by approximately 100 times compared to using free antibodies. The improvements in neutralizing the virus are attributed to two factors: first, the shells act as a physical barrier that blocks the virus from interacting with host cells; second, the multivalent binding of the antibodies inside the shells lead to stronger attachment to the trapped virus, a phenomenon known as avidity. Pre-incubation of shells with HBV and simultaneous addition of both components separately to cells lead to comparable levels of neutralization, indicating rapid trapping of the virions by the shells. Our study highlights the potential of the DNA shell system to rationally create antivirals using components that, when used individually, show little to no antiviral effectiveness.
Impact Factor
Scopus SNIP
Altmetric
8.500
0.000
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Dna Origami ; Antivirals ; Hepatitis B Virus ; In Vitro Neutralization ; Viral Blocking
Sprache englisch
Veröffentlichungsjahr 2024
HGF-Berichtsjahr 2024
ISSN (print) / ISBN 1944-8244
e-ISSN 1944-8252
Quellenangaben Band: 16, Heft: 20, Seiten: 25836-25842 Artikelnummer: , Supplement: ,
Verlag ACS
Verlagsort Washington, DC
POF Topic(s) 30203 - Molecular Targets and Therapies
Forschungsfeld(er) Immune Response and Infection
PSP-Element(e) G-502700-003
G-502799-701
Scopus ID 85192764945
PubMed ID 38728653
Erfassungsdatum 2024-06-12